CL, B., S, G., J, N., EF, F., & EE, M. (2026). Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder. Psychiatric services (Washington, D.C.), appips20250646. https://doi.org/10.1176/appi.ps.20250646
Chicago Style (17th ed.) CitationCL, Barry, Gutkind S, Niederdeppe J, Fowler EF, and McGinty EE. "Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder." Psychiatric Services (Washington, D.C.) 2026: appips20250646. https://doi.org/10.1176/appi.ps.20250646.
MLA (9th ed.) CitationCL, Barry, et al. "Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder." Psychiatric Services (Washington, D.C.), 2026, p. appips20250646, https://doi.org/10.1176/appi.ps.20250646.